Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease. - Wikidata - awgldk - TriplyDB

Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.

Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.

http://www.wikidata.org/entity/Q38038126

about

Mitochondrial dysfunction in Parkinson's disease Combined immunotherapy with "anti-insulin resistance" therapy as a novel therapeutic strategy against neurodegenerative diseases.α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production Alpha-synuclein function and dysfunction on cellular membranes.Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways.Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.Glycated proteome: from reaction to intervention.Non-enzymatic glycation and glycoxidation protein products in foods and diseases: an interconnected, complex scenario fully open to innovative proteomic studies.The pathomechanisms underlying Parkinson's disease.The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.Analytical approaches to the diagnosis and treatment of aging and aging-related disease: redox status and proteomics.Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast Glycation in Parkinson's disease and Alzheimer's disease.Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention.Prenatal activation of maternal TLR3 receptors by viral-mimetic poly(I:C) modifies GluN2B expression in embryos and sonic hedgehog in offspring in the absence of kynurenine pathway activation.Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway.Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease.Advanced Glycation-Modified Human Serum Albumin Evokes Alterations in Membrane and Eryptosis in Erythrocytes.Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease.Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases.

P2860

Q26741872-C3186468-A919-4ACF-AA22-981399934E4E Q33731321-93F126E4-4DBC-435E-8716-8E1DA5569E11 Q33841149-4E09498A-8171-44E6-9A44-60485A1D5C8A Q34774324-77DD8E20-D04D-4027-B05C-254D4F7E99F9 Q35168349-B9B3054A-248B-42CE-95BF-BB88CAE40DEA Q35996880-40488D38-D646-498C-8CA0-CAE3B0DBF902 Q38039857-8EA2EDBD-0F84-4BBE-9E6F-4AA18C38F9B8 Q38062900-AF22953C-C629-43F1-B0BD-EC13EC28A9ED Q38151611-24D5EC1D-630B-4596-B7FA-51B6C4603AE2 Q38182660-530F611C-F13B-4472-90E5-8AF80B968157 Q38241689-D1C0FF4F-8FF5-47B2-999C-DA6574024D22 Q38396814-4B3338E2-03A3-4977-8AAE-FF3062264997 Q38444052-9CFF0DC7-8128-4899-8C95-AFF61FFFF7D9 Q38762228-F687DF85-CE3A-4373-B66D-766E153F2130 Q38825497-46CD68C8-A370-4E65-9B8B-1BA58487E80C Q39368611-85BDFDEE-3BE5-4F97-8C5D-31B4252FA1EA Q42273974-65B4F530-F5ED-4F91-B2B1-F65955C3F095 Q42705625-E7E152E7-8683-44B0-97C0-F0E05B2DEE58 Q48664693-1E68CD89-74E3-4E7A-AE59-9FFB41EEA2EA Q50438327-36AB0539-8A3F-40E8-B7DD-0C2283AEB505 Q55226753-E81E7F5B-2071-4A56-A35C-586065DF83AD Q55709517-6D182FAC-F29C-470E-AC0B-51BC9ED5244B

P2860

Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.

http://www.wikidata.org/entity/Q38038126

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Recent advances in α-synuclein ...... tions for Parkinson's disease.

@en

type

label

Recent advances in α-synuclein ...... tions for Parkinson's disease.

@en

prefLabel

Recent advances in α-synuclein ...... tions for Parkinson's disease.

@en

P1433

Q38038126-4D90D4A8-892C-4A65-B419-98338E677F62

P1476

Q38038126-2904A793-8A93-417A-B7C5-CF1DEBC13F71

P2093

Q38038126-2253AB55-FA0E-43B6-A06F-ED04A15B868F

Q38038126-458FAC82-4BD7-4B13-869D-B6C81602BECC

Q38038126-DCC7AB54-ACF5-4CD9-816E-7CBB199D7B9A

P2860

Q38038126-00B9905E-2772-4226-B6AD-13336481D651

Q38038126-07C1300F-075F-409B-8B7A-43BE1C0CAAAC

Q38038126-108D29B6-6986-4215-87D6-BF79765E7941

Q38038126-11A88C08-7DBE-4C45-8A1E-2A0DFAE840E1

Q38038126-180BAD03-5105-46A1-BE2D-262A74E0562F

Q38038126-19BF5902-D6CC-4A03-8110-C8EC90566328

Q38038126-1F4F8928-8A6D-4153-9CF4-046DFC32B6A4

Q38038126-1F878336-DD3B-4B75-A09F-5DDB009BFD7D

Q38038126-22712777-73D4-4F08-8925-C82C095808D5

Q38038126-22D6ABD9-33E5-4130-808B-99CD4592CECB

P2888

Q38038126-21C47EE1-828C-44AB-94EB-2A6D0F5951D4

P304

Q38038126-FC167C37-1A0C-4631-B7C1-03EA40180F75

P31

Q38038126-217CB9AF-7E25-406B-A0DB-58E58C481BFA

P356

Q38038126-25085597-EC65-4510-991B-8FBA014C520B

P433

Q38038126-523C9302-C1C8-4EEF-BFD7-92DB26A2356E

P478

Q38038126-DC1CA8FB-71B1-44CC-B990-FC1E6C2CEF4E

P50

Q38038126-30D53C3E-296E-4236-9174-FE631B70B9C4

Q38038126-B9DB366A-C5D1-4959-ACD0-7D639750AD37

P577

Q38038126-D9346673-7E2F-40F8-B164-FDC962D13865

P5875

Q38038126-C1F0B3F9-4D97-4F93-BD28-01032DC8F9A5

P6179

Q38038126-82007BF8-B535-4592-B850-0664C767F7E8

P698

Q38038126-163225CA-36D1-4A06-A022-3889607AEFE5

P921

Q38038126-68BF0804-E6EC-419D-8DF2-67BCAEB2860E

Q38038126-F38F154B-8446-40B5-B96C-06B79A551416

P356

S12035-012-8328-Z

P1433

Molecular Neurobiology

P1476

Recent advances in α-synuclein ...... tions for Parkinson's disease.

@en

P2093

G B Britton

http://www.w3.org/2001/XMLSchema#string

K S Rao

http://www.w3.org/2001/XMLSchema#string

P Vasudevaraju

http://www.w3.org/2001/XMLSchema#string

P2860

Parkinson's Disease: Genetics and Pathogenesis

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

The sour side of neurodegenerative disorders: the effects of protein glycation.

P2888

s12035-012-8328-z

P304

525-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12035-012-8328-Z

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Muralidhar L. Hegde

P577

2012-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230742199

http://www.w3.org/2001/XMLSchema#string

P6179

1040606261

http://www.w3.org/2001/XMLSchema#string

P698

22923367

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease